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ABSTRACT Anesthetic potency increases at lower temperatures. In contrast, the transfer enthalpy of volatile anesthetics
from water to macromolecules is usually positive. The transfer decreases at lower temperature. It was proposed that a few
selective proteins bind volatile anesthetics with negative AH, and these proteins are involved in signal transduction. There has
been no report on direct estimation of binding AH of anesthetics to proteins. This study used isothermal titration calorimetry
to analyze chloroform binding to bovine serum albumin. The calorimetrically measured AHca, was -10.37 kJ - mol-1. Thus
the negative AH of anesthetic binding is not limited to signal transduction proteins. The binding was saturable following
Fermi-Dirac statistics and is characterized by the Langmuir adsorption isotherms, which is interfacial. The high-affinity
association constant, K, was 2150 ± 132 M-1 (KD = 0.47 mM) with the maximum binding number, Bmax = 3.7 ± 0.2. The
low-affinity K was 189 ± 3.8 M-1 (KD = 5.29 mM), with a Bm. of 13.2 ± 0.3. Anesthetic potency is a function of the activity
of anesthetic molecules, not the concentration. Because the sign of AH determines the temperature dependence of
distribution of anesthetic molecules, it is irrelevant to the temperature dependence of anesthetic potency.
INTRODUCTION
The hydrophobic interaction of anesthetics is well known by
the Meyer-Overton rule, where the potency of anesthetics
correlates linearly with their olive oil/water partition coef-
ficient. Because olive oil is a mixture of several compo-
nents, octanol is now preferred to represent the organic
phase. Octanol/water partition coefficient is now estab-
lished as a standard hydrophobicity parameter in the quan-
titative structure-activity relationship (QSAR) in analyzing
the binding of a ligand to host molecules (Hansch, 1971).
Oil/water partition coefficients of volatile anesthetics de-
crease when the temperature is lowered (positive tempera-
ture dependence), whereas anesthetic potencies increase
(negative temperature dependence).
To deal with this inconsistency, Dickinson et al. (1993)
expressed EC50 (the concentration that anesthetizes 50% of
the population) by
EC50 = AHIRT + constant
and proposed that the negative AH of anesthetic binding is
imperative to satisfy the negative temperature dependence
of anesthetic potencies. They reported that the enthalpy of
anesthetic binding to firefly luciferase was negative, and
proposed that only a few selected proteins are involved in
anesthesia mechanisms. The enthalpy was estimated from
the temperature dependence of anesthetic action on the light
intensity of firefly luciferase.
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To our knowledge, there has been no direct binding study
to estimate the AH of anesthetic-protein complex formation.
This study used isothermal differential titration calorimetry
(DTC) to measure the AHcal of chloroform binding to lipid-
free bovine serum albumin (BSA). Studies of the binding
mode of anesthetics have difficulty in maintaining constant
concentrations of highly volatile agents during the proce-
dure. DTC has the advantage of estimating the association
constant by avoiding the separation procedure, thereby leav-
ing the equilibrium state of binding undisturbed. From the
DTC data, the free and bound ligand concentrations were
obtained, and the association constant was estimated.
MATERIALS AND METHODS
BSA (essentially fatty acid free) was obtained from Sigma (St. Louis, MO),
and chloroform was from EM Science (Cherry Hill, NJ). Water was
purified by distillation followed by two-stage mixed-bed ion-exchanger
columns, an activated charcoal column, and an ultrafilter.
BSA was dissolved in 0.1 M phosphate buffer (pH 6.0) at various
concentrations. The solvent pH value of 6.0 was selected to avoid the
pH-induced conformational changes of BSA: N=F transition below pH
4.5 and N=B transition above pH 7.0. Chloroform was dissolved in the
same buffer. To cover an extended ligand/host concentration ratio, three
BSA concentrations were used: - 1.0, 0.1, and 0.01 mM. The chloroform
concentration was set at about 50 mM. The chloroform concentration
appears to be excessive when compared to BSA concentration, but chlo-
roform is diluted to about 1/65 when injected into the BSA solution. The
theory for the interpretation of the calorimetry data of this weakly binding
ligand is described in the Appendix.
The solvent density was measured by a pycnometer with an internal
volume -12 cm3. The density was 1.007 g _ cm-3 at 25.0°C. This value
was used to calculate the molarity of the solutes in the sample solutions.
An OMEGA differential titration calorimeter (Microcal, Northampton,
MA) was used. The titration cell (1.2955 cm3) was filled with the BSA
solution and titrated with chloroform solution in the injection microsyringe
at 25°C. The chloroform solution was injected into the BSA solution in
fractional doses under automatic control from the system computer. The
volume of each injection was 20 ,ul, and the intervals between injections
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were 10 min. To correct for the dilution effect by the injection of chloro-
form solution, two controls were obtained: titrating the BSA solution by the
buffer for BSA dilution, and titrating the buffer solution by chloroform
solution for dilution of chloroform. The overflow of the reaction mixture
by injection of ligand solution was corrected by the computer.
RESULTS
Fig. 1 shows the DTC data of BSA titration by chloroform.
The left figure is the highest BSA concentration, where
0.998 mM BSA was titrated with 53.9 mM chloroform. The
center figure is the intermediate, where the BSA/chloroform
concentration ratio was 0.101/56.3 mM, and the right figure
is the lowest ratio, 0.0105/51.4 mM.
Fig. 1 A shows the raw titration data. The upper tracings
(marked 1) show the computer-controlled injection of 20 gl
chloroform solution into the BSA solution in the titration
chamber. The area under the kth downward spike represents
the amount of heat, AQ(k), released at the kth injection. The
lower tracings (marked 2) are the control, created by inject-
ing the same volume of buffer solution without chloroform
into the BSA solution. The area under the kth upward spike
represents the amount of heat, AQ0(k), absorbed by the
dilution of the BSA concentration at the kth injection. Con-
trary to the expectation that the dilution heat of chloroform
is large, the injection of chloroform solution into the buffer
solution showed negligibly small upward peaks (<0.1
,ucal/s) and was ignored.
The difference between the two, LQ(k) - zQ0(k), rep-
resents the total amount of heat released during the injec-
tion. It consists of the partial molar enthalpy change of the
anesthetic-protein complex formation and the partial molar
enthalpy change of the free ligand in the solution.
Fig. 1 B is the integrated titration heats per mole of
chloroform during injection. The lower tracing (marked 1)
is the titration with chloroform, and the upper tracing
(marked 2) is the control without chloroform. Fig. 1 C
represents the molar enthalpy change between the absence
and presence of chloroform after correcting the BSA dilu-
tion factor (h - ho). It is plotted as a function of mole ratio
of chloroform to BSA.
From the initial slope of the curve at high BSA concen-
tration (0.998 mM) and from the final slope of the curve at
low BSA concentration (0.01 mM), the averaged enthalpy
changes of the chloroform-BSA complex formation and the
numbers of bound and free chloroform concentrations at
each injections were obtained (see Appendix). The averaged
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FIGURE 1 Isothermal titration calorimetry profiles at 25'C. Figures are from the left. BSA/chloroform ratio 0.998/53.9 rnM, 0.101/56.3 mM, and
0.0105/51.4 mM, respectively. (A) Raw titration tracing. Ordinate is the heat flow (,ical - s- '). Abscissa is the time elapsed. Downstroke is the heat evolved
and upstroke is the heat absorbed. 1: Titration with chloroform solution; 2: titration with buffer alone. (B) Integrated titration heat for each injection.
Ordinate is the area under each peak (,ucal). Abscissa is the injection number. 1: Titration with chloroform solution; 2: titration with buffer alone. (C)
Difference in the molar enthalpy of the BSA solution between the absence and presence of chloroform at each injection. Abscissa is the chloroform/BSA
mole ratio.
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enthalpy change of chloroform-BSA complex formation is
assumed to be the standard molar enthalpy change, AH, of
chloroform. The values of the three BSA concentrations
were similar, and the averaged AHcal value was -10.37 ±
0.29 kJ * mol-'. The binding isotherms are constructed in
Fig. 2 from the free and bound chloroform concentrations.
By fitting free and bound anesthetic molecules to the
Scatchard plot (Fig. 3), the affinity constants and the bind-
ing numbers of chloroform to BSA were estimated. These
plots were nonlinear. It indicates multiple classes of binding
sites. Because of the difficulty of identifying many inter-
mediate classes of binding, the high- and low-affinity bind-
ing classes were analyzed. The high-affinity interaction was
estimated at the lowest chloroformlBSA concentration ratio,
where almost all added chloroform molecules are bound to
BSA. This corresponds to the initial part of the titration in
the high BSA concentration. The low-affinity interaction
was estimated at the highest chloroformlBSA concentration
ratio, where almost all chloroform-binding sites are occu-
pied. This corresponds to the final part of the titration in the
low BSA concentration. The results showed that the high-
and low-affinity association constants, K, were 2150 ± 132
(KD = 0.47 mM) and 189 ± 3.8 M-1 (.
respectively, and the maximum binding
high- and low-affinity binding were 3.7
0.3, respectively.
The thermodynamic parameters were e;
affinity constant, K, by the equation
-RTln K = AG = AH -T
where R is the gas constant, T is the absolu
is the Gibbs free energy, and S is the entr
dynamic parameters for the high- and lov
tions were AG = -19.0 kJ * mol-F
J * K- l - mol-1 for high-affinity binding
kJ - mol-1 and AS = 8.8 J * K-1 * mol-
binding.
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FIGURE 3 The Scatchard plot. Ordinate: the ratio between bound and
free chloroform. Abscissa: bound chloroform molecule. Cx is the molarity
of free ligand molecules, and b is the averaged number of ligand molecules
bound to a BSA molecule. The symbols are the same as Fig. 2.
DISCUSSION
Anesthetic-protein binding mode
KD = 5.29 mM), Reports on the binding of volatile anesthetics to proteins are
numbers for the few. Dubois and Evers (1992) used 19F-NMR and gas
t 0.2 and 13.2 ± chromatography for isoflurane binding to BSA and reported
that the dissociation constant, KD, was 1.4 mM, with a
stimated from the maximum binding number of 3-4. Dubois et al. (1993)
reported KD values of three other anesthetics on BSA, also
"S, using 19F-NMR: halothane, 1.3 mM; methoxyflurane, 2.6
mM; and sevoflurane, 4.5 mM. The binding of anesthetics
ite temperature, G was inhibited by oleic acid, and they concluded that anes-
opy. The thermo- thetics bind to BSA at or near the oleic acid-binding site.
v-affinity interac- However, by a photoaffinity labeling study, Eckenhoff
and AS = 28.1 (1996) determined the [14C]halothane binding site on BSA.
and AG =-12.9 He demonstrated that the halothane-binding domain is dif-
for low-affinity ferent from the oleic acid-binding domain. Eckenhoff and
Shuman (1993) used photoaffinity labeling with [14C]halo-
thane to estimate binding to several lipid-free proteins and
polypeptides. They reported that the KD of halothane bind-
ing to BSA was 0.3-0.5 mM. Johanson et al. (1995) used
intrinsic fluorescence and obtained a KD of 1.8 mM for
aCwo0HM halothane binding to BSA.
The present study showed that the binding was saturable,
2 following Fermi-Dirac statistics (Eyring et al., 1982). The
data conformed the Langmuir adsorption isotherms, which
is interfacial.
Because the Scatchard plot was nonlinear, the association
constant, K, is not a single value and consists of at least two
binding classes. The values for the high- and low-affinity
bindings were, respectively, 2150 M-1 (KD 0.47 mM) and
-
2
189 M-1 (KD 5.3 mM) for the affinity constants, and 3.7
1520 and 13.2 for the maximum binding numbers.
These differences between high- and low-affinity bind-
SA at 250C. Ordinate: ings, plus the differences in experimental methods and the
scissa: free chloroform choice of plotting equations, probably explain the wide
),0.998 mM; A, 0.101 variation in the reports on the dissociation constants of
anesthetics with proteins.
3
2
1 ~ ~~~1 1 1
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Hydrophobic interaction has long been considered an en-
tropy-driven process with positive AlH values. Recently,
however, the hydration effect on nonpolar solute in water
and the resulting change in the heat capacity of the solutes
led to scrutinization of the concept of hydrophobic effect
(Baldwin, 1986; Murphy et al., 1990; Dill, 1990). Seelig
and Ganz (1991) reported that several hydrophobic ligands
interacted with lipid membranes with negative AH. They
denoted the binding with negative Al as a "nonclassical"
hydrophobic effect, as opposed to the "classical" hydropho-
bic effect, where AH is positive.
Katz and Diamond (1974) reported that when the water
solubility of ligand decreases, the affinity constant increases
and the enthalpy change of the ligand transfer from water
(w) to lipid (1), AHwEl, becomes less positive, and the sign
would eventually shift from positive to negative. They pre-
dicted that in the alcohol series, elongation of the hydrocar-
bon chain increases the lipid/water partition coefficients and
ultimately reverses the sign of AHwl to a negative value.
Rowe et al. (1995) reported that the binding of octanol to a
variety of phospholipid bilayer membranes is accompanied
by negative AHw >1 in the range of -1 to -2 kcal/mol (-4
to -8 kJ * mol-1).
Together with the present negative AHwp (where sub-
script p signifies protein) of chloroform interaction with
BSA, negative AH of transfer of anesthetics from water to
macromolecules is not limited to the selected signal trans-
duction proteins.
Temperature dependence of anesthetic potency
It is important to distinguish between concentrations and
activities of anesthetics when dealing with potencies. Fer-
guson (1939) stressed the importance of anesthetic activities
at the action site, which is difficult to obtain. He used the
chemical potential of anesthetics, which is equal in all
phases in equilibrium, and defined the "thermodynamic
activity" of anesthetics. Thermodynamic activity is ex-
pressed by the ratio of anesthetic partial pressure in the gas
phase that anesthetizes half the population, and the vapor
pressure of the anesthetic at the same temperature. It is
analogous to relative humidity. The humidity one feels is
not the amount of water molecules contained in the air
(absolute humidity). It is the ratio [water content in the
air]/[saturating water content in the air at the same temper-
ature] (relative humidity). When the temperature decreases,
the amount of saturating water vapor in the gas phase
decreases. One feels more humid at lower temperatures,
even though the water content in the air remains constant.
When the anesthetic potency is expressed by MAC (min-
imum alveolar concentration of anesthetics that induces
anesthesia in 50% of the population), the thermodynamic
activity of anesthetics is the ratio between MAC (expressed
anesthetics (reference) at the same temperature. The refer-
ence vapor pressure is taken in a one-component, two-phase
system. Because the degree of freedom is 1, the vapor
pressure is fixed by the temperature. Anesthetic potency
expressed by partial pressure always increases (MAC de-
creases) at low temperatures because the vapor pressure of
neat anesthetic must decrease at lower temperatures, as
dictated by the phase rule. It is the thermodynamic activity
of anesthetics that determines the anesthetic potency, not the
number of anesthetic molecules present at the action site. Of
course, an increase in the number of anesthetic molecules at
the action site increases the potency when the anesthetic
vapor pressure remains constant. The potency of anesthetics
is not absolute to their concentrations, but is relative to their
standard state.
The statement of Dickinson et al. (1993) that anesthetic
potency always increases at lower temperature fails when
the anesthetic concentration is expressed by aqueous con-
centrations. Anesthetic potencies vary, depending upon
where the concentration is measured. When the concentra-
tion is expressed in the gas phase, the rank order of potency
is methoxyflurane > chloroform > halothane > isoflu-
rane > enflurane > diethylether. When the concentration is
expressed in the aqueous phase, the order is halothane >
isoflurane > methoxyflurane > enflurane > chloroform >
diethylether. The variation is caused by the difference in the
solvation of anesthetics in water.
Cherkin and Catchpool (1964) showed that low temper-
ature decreased the potency of diethylether. The EC50 of
diethylether in goldfish was 1.85 g/liter water at 30°C and
increased to 2.56 g/liter water at 5°C. In contrast, the EC50
of halothane was 0.0935 g/liter water at 30°C and decreased
to 0.0467 glliter water at 5°C. When the aqueous concen-
trations are used, lower temperature does not necessarily
increase the anesthetic potency.
These discrepancies occur because the anesthetic potency
is expressed by the concentration in an arbitrary phase.
Anesthetic potency is a function of activity, not concentra-
tion. The sign of AH measures the temperature-dependent
balance of anesthetic concentrations in two phases. Hence
the sign of AHw ,p has little importance for the temperature
dependence of anesthetic potency.
Living animals are in a highly complex dynamic state of
the network of numerous systems. A change in the temper-
ature induces a cascade of a series of stress reactions,
involving hormone levels and other signal transduction
pathways. The problem of how these changes affect con-
sciousness remains.
APPENDIX
Consider a system composed of a solution of n' moles of protein M and
nT moles of ligand X dissolved in nw moles of solvent W. Provided that the
protein molecule has q sites, each capable of combining with the ligand
by partial pressure) and the vapor pressure of the neat
1815Ueda and Yamanaka
molecule, then q species of protein-ligand complex MXi (i = 1, 2, . . , q)
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are formed in the solution. The enthalpy of such a system is written in the
form
q
H = nwhw + nxhx + Enihi,(1)
i=O
where nw and hw are the number of moles and the partial molar enthalpy
of the solvent, respectively; nx and hx are those of the free ligand; and n
and hi are those of the free protein (i = 0) and of the complex MXi (i =
1, 2, . . ., q). The numbers of moles of total ligand and protein molecules
are given by
q
nT = nx +> ini (2)
i=O
and
q
nM E ni
i=O
respectively. Eq. 1 can be written in the form
q
H = nwhw + nT ho + nTihx + I ni(hi- ho- ihx).
(3)
(4)
i=O
The fourth term of the right side of this equation is related to the formation
of the protein-ligand complexes. If we define the averaged partial molar
enthalpy change of the complex formation per ligand molecule Ah by
Ah =0 n1(hi - ihx)
A=
- ini
respectively, where superscript 0 means the solution without the ligand. If
we assume that the partial molar enthalpies of solvent and free protein in
the solution with ligand are equal to the corresponding partial molar
enthalpies in the solution without ligand, the difference in the enthalpy
between the solutions with or without ligand Hdif (the net change in the
enthalpy by the addition of ligand to the solution) gives the third and fourth
terms of the right side of Eq. 7:
Hd" =H - Ho = nxhx + n'bAh. (12)
Furthermore, using Eqs. 9 and 11, we obtain the total differential of HdIf in
the form
dHdif = hxdnx + Ahd(nT b). (13)
In the practical analysis of experimental data, thermodynamic quantities
per mole of protein are often used. Dividing Eq. 12 by nm, we obtain the
enthalpy difference per mole of protein:
Hdif nT
hdif T =- hx + bAh = akhx + bAh.nMT nTM (14)
Using Eqs. 12 and 13, the total differential of hdif is derived as follows:
dif d d)d() + Ahdb = hxda + Ahdb.
(15)
In Eqs. 14 and 15, we have introduced ak (= nx/nm) to denote the molar
ratio of total ligand molecules to total protein molecules. Applying Eqs. 14
and 15 to the experimental data of hdif as a function of aT, we obtain
information about the protein-ligand binding. From Eq. 15 we have
(dhdif\ (db\
ta tT = hx + Aht TaT,aax) aaTT,p X T,p(5)
and the averaged number of ligand molecules bound to a protein molecule
b by
(16)
Because most of the binding sites on protein molecules are empty in the
very low range of ax, almost all of the ligand molecules added in the
system bind to the protein molecules, i.e.,
>:=inin n -nx
=I i
,-0ni
we obtain
H = nwhw + nT ho + nTho + nThx + nTbAh.
(6)
(7)
Because the enthalpy of the system is a function of temperature T,
pressure p, nw, nx, and ni (i = 0, 1, . . ., q), its total differential at constant
temperature and pressure is written in the form
dH = hwdhw + hxdnx + E hidni.
i=O
Similarly, from Eqs. 1-7 we can derive
dH = hwdnw + hodnT + hxdnT + Ahd(nTb).
(b \
aax) (17)
so that we have
(18)9h
dif
li
aa
= hx + Ah.
a-) X T,p
On the other hand, in the very high range of ax, the binding sites are almost
saturated by the ligand molecules, i.e.,
(8) (:b) 0,dafx T,p ° (19)
and we have
(9)
For a solution composed of the same amount of solvent and protein as
above, but without ligand, the enthalpy of this solution and its total
differential at constant temperature and pressure are given by
Ho = nwho + nTho (10)
(ahdif\
lim aaT =hx.
ax-O
(20)
Thus we can obtain the partial molar enthalpy of ligand hx by using Eq. 20,
and the averaged partial molar enthalpy change of the complex formation
per ligand molecule Ah by using
and
dH° = hwdnw + hodnT,
ahdif\Iahdif
Ah= lim aa - lrn a T)p
aT--3o0 XT,p aiT-4> T,p
(21)
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Furthermore, because Eq. 14 is rewritten as
hdif - caThx
b h =
-(22)
the averaged number of ligand molecules, b, bound to a protein molecule
can be estimated.
This study was supported by the DVA Medical Research Funds.
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